Newsbenzinga
CRISPR Therapeutics To Present Phase 1b Data For CTX310 In Severe Hypertriglyceridemia In Late-Breaking AHA Presentation On November 9
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…